SCHEMBL6945301

SCHEMBL6945301

Cc1nc(N2CCc3ccccc3CC2)c([N+](=O)[O-])c(=O)n1CCCCO[Si](C)(C)C(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DUT P33316 1/20 0.35
CYP2C9 P11712 2/20 0.34
CYP2D6 P10635 1/20 0.34
MAPT P10636 4/20 0.33
HTR1A P08908 3/20 0.33
HTR7 P34969 3/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
GPR55 Q9Y2T6 1/20 0.33
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
POLB P06746 1/20 0.32
MGMT P16455 1/20 0.32
ATM Q13315 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
EED O75530 1/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6950955 0.84 CYP2C9 (0.35) CYP2C9CYP2D6MAPTHTR1AHTR7
SCHEMBL6949181 0.83 TSHR (0.43) CYP2C9CYP2D6MAPTHTR1AHTR7
SCHEMBL6952822 0.83 CYP2C9 (0.39) CYP2C9CYP2D6MAPTHTR1AHTR7
SCHEMBL4416893 0.82 DUT (0.34) DUTMAPTHTR1AHTR7POLB
SCHEMBL6949240 0.82 TSHR (0.46) CYP2C9CYP2D6MAPTHTR1AHTR7
SCHEMBL6951480 0.81 CYP2C9 (0.35) CYP2C9CYP2D6MAPTHTR1AHTR7
SCHEMBL6947669 0.81 MGMT (0.40) DUTCYP2C9MAPTHTR1AHTR7
SCHEMBL6952584 0.81 CYP2C9 (0.40) CYP2C9CYP2D6MAPTCYP1A2CYP3A4
SCHEMBL6949137 0.81 CYP2D6 (0.44) CYP2C9CYP2D6MAPTGPR55MEN1
SCHEMBL6953752 0.80 CYP2C9 (0.40) CYP2C9CYP2D6MAPTCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed